Don Drakeman
Venture Partner @ Advent Venture Partners
New York, United States
Don Drakeman is a startup investor at Advent Venture Partners in New York. Don joined Advent in 2007 after 25 years as an entrepreneur and chief executive in the biotechnology industry, during which he co-founded Medarex Inc and Genmab A/S, both of which grew to be multi-billion dollar companies. Don has overseen the progression of numerous innovative medical products for cancer, infectious disease and inflammationfrom research concept to clinical trials. Several of them have now become FDA-approved products, including pioneering cancer treatments Yervoy® and OpdivoTM.Don takes Advisory, Board and senior non-executive roles with our portfolio companies, including 4-antibody, Capella Biosciences and Aleta Inc.Don received an AB from Dartmouth College, a JD from Columbia University and a PhD in the Humanities from Princeton University, where he has served as a member of the Faculty. He is currently a Fellow in Health Management at the University of Cambridge.
Last updated:
For AI agents: llms.txt
About Advent Venture Partners
Advent Venture Partners is one of Europe's most successful growth and venture capital investors in market-leading tech and life sciences businesses. They have designed their strategy, teams and funds so they can focus on backing a select few companies. They pride their selves on establishing true partnerships with entrepreneurs in order tobuild valuable businesses together.
Advent Venture Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Don Drakeman
Venture Partner
|
|||
Les Gabb
Founder & Finance Partner
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
